You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 109 No. 1, January 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  Letter to the Editor
 This Article
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Vocal Cord Carcinoma-Reply

BRACE L. HINTZ, MD; A. ROBERT KAGAN, MD; HERMAN NUSSBAUM, MD; PAUL Y. M. CHAN, MD; JOHN MILES, MD
Los Angeles

Arch Otolaryngol. 1983;109(1):62.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—We realize that our approach to in situ vocal cord carcinoma (VCC) is controversial, and we did not intend at this time to imply strong advocacy of a watchful waiting policy outside the confines of a research setting. The main purpose of our article was to present data—gathered from patients with VCC who were supervised by one group of physicians within a controlled environment—to illuminate the natural course of in situ laryngeal carcinoma and to note advantages and disadvantages of both the immediate treatment and watchful waiting approaches.

We did not discuss psychological issues in the original article, however. Anyone who deals with patients can appreciate the great psychosocial difficulties inherent in leaving noninvasive lesions untreated after the referring physician has already told the patient that he has cancer. It is certainly less stressful for the physician—and for the patient—to engage in immediate, definitive therapy for in situ lesions.

We . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.